Table 3a.
Prevalence of HPV genotypes covered by the bi-, quadri-, and nonavalent vaccines by histological diagnosis.
| N=380a (%) |
≤ CIN 1 N=217 |
CIN 2± N=163 |
X2 P-Value |
|
|---|---|---|---|---|
| <0.001 | ||||
| Bi-/Quadrivalent coverage | 115 (27.4%) | 24.4% | 38.0% | |
| Nonavalent coverage | 146 (34.8%) | 32.7% | 46.0% | |
| Not covered by any vaccine | 119 (28.4%) | 42.9% | 16.0% |
a
Histology data are missing for 39 of the 419 cases included in the overall analysis.
bParticipants were considered ‘not covered’ if no types in their sample were included in any vaccine.